These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 23677053)
1. Use of pharmacogenetics for predicting cancer prognosis and treatment exposure, response and toxicity. Hertz DL; McLeod HL J Hum Genet; 2013 Jun; 58(6):346-52. PubMed ID: 23677053 [TBL] [Abstract][Full Text] [Related]
2. Germline genetic variation, cancer outcome, and pharmacogenetics. Coate L; Cuffe S; Horgan A; Hung RJ; Christiani D; Liu G J Clin Oncol; 2010 Sep; 28(26):4029-37. PubMed ID: 20679599 [TBL] [Abstract][Full Text] [Related]
3. Pharmacogenetics of cancer drugs. Hertz DL; Rae J Annu Rev Med; 2015; 66():65-81. PubMed ID: 25386932 [TBL] [Abstract][Full Text] [Related]
4. Somatic pharmacogenomics in cancer. Ikediobi ON Pharmacogenomics J; 2008 Oct; 8(5):305-14. PubMed ID: 18679398 [TBL] [Abstract][Full Text] [Related]
5. Using germline genotype in cancer pharmacogenetic studies. McWhinney SR; McLeod HL Pharmacogenomics; 2009 Mar; 10(3):489-93. PubMed ID: 19650256 [TBL] [Abstract][Full Text] [Related]
6. Challenges of SNP genotyping and genetic variation: its future role in diagnosis and treatment of cancer. Bernig T; Chanock SJ Expert Rev Mol Diagn; 2006 May; 6(3):319-31. PubMed ID: 16706736 [TBL] [Abstract][Full Text] [Related]
7. Cancer pharmacogenetics. Marsh S Methods Mol Biol; 2008; 448():437-46. PubMed ID: 18370241 [TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetics for individualized cancer chemotherapy. Efferth T; Volm M Pharmacol Ther; 2005 Aug; 107(2):155-76. PubMed ID: 15890408 [TBL] [Abstract][Full Text] [Related]
9. Pharmacogenetics and biomarkers in colorectal cancer. Strimpakos AS; Syrigos KN; Saif MW Pharmacogenomics J; 2009 Jun; 9(3):147-60. PubMed ID: 19381163 [TBL] [Abstract][Full Text] [Related]
10. Primer on medical genomics. Part XII: Pharmacogenomics--general principles with cancer as a model. Goetz MP; Ames MM; Weinshilboum RM Mayo Clin Proc; 2004 Mar; 79(3):376-84. PubMed ID: 15008610 [TBL] [Abstract][Full Text] [Related]
11. Exploring the human genome in cancer with genomic approaches. Scheel JR; Kuo MD J Vasc Interv Radiol; 2006 Aug; 17(8):1225-33. PubMed ID: 16923971 [No Abstract] [Full Text] [Related]
12. Pharmacogenomics in breast cancer: current trends and future directions. Wajapeyee N; Somasundaram K Curr Opin Mol Ther; 2004 Jun; 6(3):296-301. PubMed ID: 15264432 [TBL] [Abstract][Full Text] [Related]
13. Pharmacogenetics in chemotherapy of colorectal cancer. Henriette Tanja L; Guchelaar HJ; Gelderblom H Best Pract Res Clin Gastroenterol; 2009; 23(2):257-73. PubMed ID: 19414151 [TBL] [Abstract][Full Text] [Related]
18. Application of genotype-guided cancer therapy in solid tumors. Patel JN Pharmacogenomics; 2014 Jan; 15(1):79-93. PubMed ID: 24329193 [TBL] [Abstract][Full Text] [Related]
19. Interpreting disparate responses to cancer therapy: the role of human population genetics. Maitland ML; DiRienzo A; Ratain MJ J Clin Oncol; 2006 May; 24(14):2151-7. PubMed ID: 16682733 [TBL] [Abstract][Full Text] [Related]